Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05949788
Other study ID # ShenzhenBMCHH
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date March 1, 2023
Est. completion date December 31, 2024

Study information

Verified date March 2024
Source Shenzhen Bao'an Maternal and Child Health Hospital
Contact Jun Luo, M.D.
Phone +86-015818671195
Email luojun-78@163.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

To study and analyze the association of the severity of anemia with neonatal morbidity and the risk factors of anemia in ealry life (less than 3 days of life) among the very low birth weight (VLBW) infants.


Description:

The rescue treatment of very low birth weight (VLBW) infants is the main task of our neonatal intensive care unit (NICU) is this era. Anemia of prematurity (AOP) is one of the most common complication of these infants, which can affect their growth, intelligence, behavior, immunity and hemodynamics, and even endanger their lives in severe situation. It is of great significance to investigate the association of the severity of anemia with neonatal morbidity and the risk factors of anemia in ealry life for improving the prognosis of these infants. Patient Registry procedures: First, the list of VLBW infants was obtained through medical record search, and sent to the principal investigator (PI) at each center when an infant was eligible for enrollment. Second, patients are included in this study according to the exclusion criteria by PI. Finally, the PI at each center will be responsible for the accuracy,completeness or representativeness of medical records, registry forms,data collection. Statistical analysis:The two groups were compared by a Χ2-test for categorical variables, Mann-Whitney U Test were used when reporting medians.A P value of <0.05 was considered statistically significant.


Recruitment information / eligibility

Status Recruiting
Enrollment 110
Est. completion date December 31, 2024
Est. primary completion date March 13, 2024
Accepts healthy volunteers No
Gender All
Age group N/A to 4 Months
Eligibility Inclusion Criteria: - Preterm infants less than 32 weeks of gestational age and birth weight below 1500 g and who survive to NICU are eligible for the trial. - Anemia was defined as a central venous hemoglobin harvested in the first 3 days of life less than two standard deviations below the mean for postnatal age. Exclusion Criteria: - Asphyxia (arterial pH <7.0, fifth minute Apgar score <3), - Twin-to twin-transfusion syndrome, - Discordant twins (difference in birth weight >20%), - Major congenital anomalies or chromosomal anomalies, - Disagree of parents.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
No intervention
Retrospect study, no direct intervention

Locations

Country Name City State
China Shenzhen Bao'an Maternal and Child Health Hospital Shenzhen Guangdong

Sponsors (2)

Lead Sponsor Collaborator
Shenzhen Bao'an Maternal and Child Health Hospital Longhua Hospital Of Baoan District, Shenzhen

Country where clinical trial is conducted

China, 

References & Publications (4)

Bellach L, Eigenschink M, Hassanein A, Savran D, Salzer U, Mullner EW, Repa A, Klebermass-Schrehof K, Wisgrill L, Giordano V, Berger A. Packed red blood cell transfusion in preterm infants. Lancet Haematol. 2022 Aug;9(8):e615-e626. doi: 10.1016/S2352-3026(22)00207-1. — View Citation

Everhart KC, Donevant SB, Iskersky VN, Wirth MD, Dail RB. Case Comparison of Preterm Infant Stability During Packed Red Blood Cell Transfusions. Nurs Res. 2023 Jul-Aug 01;72(4):301-309. doi: 10.1097/NNR.0000000000000658. — View Citation

Nesterenko TH, Baliga N, Swaintek S, Abdelatif D, Aly H, Mohamed MA. The impact of a multifaceted quality improvement program on the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatr Neonatol. 2022 Mar;63(2):181-187. doi: 10.1016/j.pedneo.2021.10.002. Epub 2021 Dec 5. — View Citation

Patel RM, Knezevic A, Shenvi N, Hinkes M, Keene S, Roback JD, Easley KA, Josephson CD. Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA. 2016 Mar 1;315(9):889-97. doi: 10.1001/jama.2016.1204. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Anemia of prematurity (AOP) development in very low birth weight (VLBW) infants The incidence of AOP in the first 72 hours of life in VLBW infants Through study completion, an average of three months
Secondary Risk factor of AOP among VLBW infants The maternal hemoglobin (Hb) levels before birth among VLBW infants with AOP and without. Through study completion, an average of three months
Secondary Mortality or Bronchopulmonary Dysplasia (BPD) among VLBW infants with AOP The incidence of death or BPD among VLBW infants with AOP and without. Through study completion, an average of three months
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05436925 - CGM Use in Preterm Infants
Completed NCT05116670 - Comparison of Care Practices, Mortality and Morbidity of Very Preterm Infants Between Two Tertiary Centers in Northwest and South of China
Recruiting NCT05711927 - Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants N/A
Recruiting NCT06076460 - Early Total Enteral Feeding Versus Convention Enteral Feeding in Preterm Infants 27-32 Weeks of Gestation N/A
Recruiting NCT05961657 - USCOM Parameters in Preterm Infants: Reference Ranges
Completed NCT06391476 - Prematurity at the Limit of Viability
Recruiting NCT04239508 - Swiss Neonatal Network & Follow-up Group
Recruiting NCT06266455 - Individualized Nutrition to Optimize Preterm Infant Growth and Neurodevelopment N/A